Targeted peptide therapy for tissue healing, injury recovery, gut integrity, and systemic inflammation β prescribed by Australian doctors.
Recovery peptides work by binding to specific receptors involved in cellular repair, angiogenesis (new blood vessel formation), and immune modulation. Unlike anti-inflammatory medications that suppress the healing cascade, these peptides work with the body's natural repair processes β accelerating what the body does naturally.
They are particularly well-studied for their effects on musculoskeletal tissue, gut epithelial integrity, and systemic inflammatory load. Our doctors assess your specific injury or condition and prescribe the combination most appropriate to your case.
These are the peptides used in our Recovery & Repair program. Your doctor determines which are appropriate for your specific presentation.
BPC-157 is a synthetic 15-amino acid peptide derived from a sequence found in human gastric juice. It has been extensively studied in preclinical models for its effects on musculoskeletal tissue repair, tendon and ligament healing, gut epithelial integrity, and systemic anti-inflammatory activity.
Mechanistically, BPC-157 promotes angiogenesis, modulates nitric oxide production, and interacts with the growth hormone receptor pathway β accelerating the natural healing cascade without the immunosuppressive effects of corticosteroids.
Thymosin Beta-4 is a naturally occurring 43-amino acid protein present in high concentrations in blood platelets and wound fluid. It plays a key role in regulating actin polymerisation β the process by which cells move and proliferate during healing.
TB-500 promotes muscle fibre regeneration, reduces inflammation, and increases cell migration to the site of injury. It is often used in combination with BPC-157 for a synergistic effect on connective tissue and muscle recovery.
Consultation with your Natura doctor. Prescription issued, pharmacy dispatch within 48h. Self-administration training provided with your kit.
Most patients begin to notice reduced inflammation and improved comfort within the first 2β4 weeks. Healing acceleration is often reported during this phase.
Tissue remodelling and repair is actively progressing. Many patients can increase their rehabilitation load during this period.
Follow-up consultation with your doctor. Progress assessed. Program continued, adjusted, or concluded based on clinical response.
Your Natura doctor makes the final determination on suitability. The eligibility assessment helps us understand your case before your consultation.
Complete the eligibility assessment and book your telehealth consultation with a Natura doctor.
The information on this page is educational and does not constitute medical advice. BPC-157 and TB-500 are unregistered medicines in Australia, prescribed under TGA prescribing authority by AHPRA-registered doctors and compounded by TGO 101-compliant pharmacists. Individual results may vary. Not suitable for patients under 18.